banner ad
Experts Logo

articles

Vertebral and Carotid Artery Dissections

By: Sajid Khan, MD

Tel: 913-271-4142
Email Dr. Khan


View Profile on Experts.com.


Cervical arterial dissections most commonly occur in the carotid arteries, followed by the vertebral arteries. Vertebral artery dissection (VAD) often presents after a trivial injury such as hyperextension of the neck while at the salon, checking a blind spot while driving, chiropractic manipulation, riding a roller coaster, or, as in my case, coughing. There are some key differences that can help distinguish carotid from vertebral dissection.

Carotid artery dissection classically presents as a 'thunderclap headache' with unilateral facial, neck or head pain and a partial Horner’s syndrome (miosis and ptosis, but not anhydrosis). About one-third of patients will have a TIA within one week (neurological symptoms lag behind because it takes time to have a thrombus formed and thrown from the site of dissection). VAD on the other hand, presents with posterior neck or occipital pain and posterior circulation symptoms (ataxia, vertigo, dysarthria, etc). Diagnosis of both conditions is made by CT-angiogram.

Carotid vertebral artery imageA systematic review of 75 published reports confirms that presentation can be nebulous: a high index of suspicion is necessary or it will be missed. This review found that the three most common presenting symptoms for VAD were dizziness (58%), headache (51%), and neck pain (46%). To put it another way, 49% of patients with VAD did not have a headache and 42% did not have dizziness. VAD is more common in younger patients with an average age of 45 years (compared to an average age of 65+ for stroke victims). While incidence has increased in the past decade (probably due to improved imaging modalities), these numbers are still hugely misleading. The reported incidence of spontaneous cervical arterial dissection is 3-5 per 100,000, but the true number of cases is no doubt much higher.

Younger stroke victims often ignore the symptoms, and because they are young and healthy, doctors may not consider stroke as a cause. This point cannot be emphasized enough: cervical artery dissections are a real cause of stroke in young people, including pediatric patients. Don’t fall prey to bias and dismiss a young person with neurologic findings (even in the absence of any risk factors).

The severity depends on whether the dissection occurs before or after the affected artery enters the skull. Intra-cranial dissection occurs in more than half of cases and has a much poorer prognosis than extra-cranial dissection. All patients with cervical artery dissection should be admitted as even those who are relatively asymptomatic may progress to ischemic stroke. Arguments could be made for neurology, neurosurgery, or interventional radiology to be the primary caretaker of such patients.

The long-term treatment is Aspirin 325 mg daily or anticoagulation with Warfarin for 3-6 months. Both have been shown to reduce the progression to ischemic stroke and no study has ever shown a significant advantage of anticoagulation over anti-platelet therapy. As a general rule, a Heparin drip should be started in the ED and, once admitted, a decision can be made about Aspirin versus Warfarin.


Dr. Sajid Khan Sajid R. Khan, MD, is a board-certified Emergency Medicine physician with over 10 years of experience working in a variety of settings from inner-city level 1 trauma centers serving 100,000 patients per year to 3-bed rural Eds. A published author, Dr. Khan has written a number of books including, The Ultimate Emergency Medicine Guide, a comprehensive review book that is the highest-rated and most up-to-date text for Emergency Medicine physicians preparing to certify.

Dr. Maryam Ashadcompleted her EM residency at Emory University and is the author of Medical Ethics 101.


©Copyright - All Rights Reserved

DO NOT REPRODUCE WITHOUT WRITTEN PERMISSION BY AUTHOR.

Related articles

Rabbie-Hanna-Gynecologic-Ocology-Expert.jpg

3/2/2016· Medical

The Role of Surgery and Radiation Therapy in the Management of Gestational Trophoblastic Disease

By: Dr. Rabbie Hanna

The primary management of hydatidiform moles remains surgical evacuation followed by human chorionic gonadotropin level monitoring. Although suction dilatation and evacuation is the most frequent technique for molar evacuation, hysterectomy is a viable option in older patients who do not wish to preserve fertility. Despite advances in chemotherapy regimens for treating malignant gestational trophoblastic neoplasia, hysterectomy and other extirpative procedures continue to play a role in the management of patients with both lowrisk and high-risk gestational trophoblastic neoplasia.

Terence-Gray-Pain-Management-Expert-Photo.jpg

8/9/2017· Medical

OnabotulinumtoxinA in the Treatment of Occipital Neuralgia Following Gunshot Injury

By: Dr. Terence Gray

Occipital neuralgia, while typically idiopathic in presentation, is a common form of posttraumatic headache. It is associated with severe pain in the greater, lesser, and/or third occipital nerves, and often accompanied by tenderness or trigger points in the surrounding musculature. OnabotulinumtoxinA (ONA) has been recently utilized in nerve blocks to treat occipital neuralgia, but current literature supporting such use is scarce. We describe a case of occipital neuralgia in a patient following C1 fracture and vertebral artery dissection due to gunshot injury. Successful treatment with bilateral ONA nerve blocks led to an 80% - 90% improvement in pain, with decreased Visual Analog Scale (VAS) pain scores immediately following treatment and upon follow-up 1 month later.

Jeffrey-Stone-Photo.jpg

3/5/2013· Medical

Thrombin Peptide Chrysalin Stimulates Healing of Diabetic Foot Ulcers in a Placebo-Controlled Phase I/II Study

By: Dr. Jeffrey Stone

Thrombin and thrombin peptides play a role in initiating tissue repair. The potential safety and efficacy of TP508 (Chrysalins) treatment of diabetic foot ulcers was evaluated in a 60-subject, prospective, randomized, double-blind, placebocontrolled phase I/II clinical trial.

;
Experts.com-No broker Movie Ad

Follow us

linkedin logo youtube logo rss feed logo